Cleared Traditional

K051553 - FUJI SYNAPSE WORKSTATION SOFTWARE

K051553 is an FDA 510(k) clearance for FUJI SYNAPSE WORKSTATION SOFTWARE, manufactured by Fujifilm Medical Systems U.S.A, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 24-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2005
Decision
24d
Days
Class 2
Risk

K051553 is an FDA 510(k) clearance for the FUJI SYNAPSE WORKSTATION SOFTWARE. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Fujifilm Medical Systems U.S.A, Inc. (Stamford, US). The FDA issued a Cleared decision on July 7, 2005 after a review of 24 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Fujifilm Medical Systems U.S.A, Inc. devices

FDA 510(k) Submission Details - K051553

510(k) Number K051553 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 13, 2005
Decision Date July 07, 2005
Days to Decision 24 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
83d faster than avg
Panel avg: 107d · This submission: 24d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Underwriters Laboratories, Inc.
JEFFREY D RONGERO

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1857
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K051553.
XELERIS 2 PROCESSING AND REVIEW WORKSTATION
K051673 · GE Medical Systems · Jul 2005
19-INCH (48CM) COLOR LCD MONITOR CDL1904A
K051403 · Totoku Electric Co., Ltd. · Jul 2005
ECHOSYSTEM
K051745 · Medstrat, Inc. · Jul 2005
BTI-SCAN, VERSION 4.0
K051392 · B.T.I. Biotechnology Institute, Sl. · Jun 2005
IMAGEQUBE PACS
K051037 · Intuitive Imaging Informatics, LLC · Jun 2005
REGIUS RS-1000, MEDICAL IMAGE PROCESSING WORKSTATION
K051521 · Konica Minolta Medical & Graphic, Inc. · Jun 2005